Genscript Biotech Corporation

Research Genscript Biotech Corporation (G51) on Bullrun: market cap EUR 2.88B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerG51
• ExchangeF
• CountryHong Kong
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 2.88B
• Financial periodFY2025
• RevenueEUR 959.53M
• Revenue growth61.4%
• Net income-EUR 532.83M
• Free cash flowEUR 241.69M
• Gross margin57.7%

Valuation Snapshot

latest market cap is EUR 2.88B.

About Genscript Biotech Corporation

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products segments.

Frequently asked questions

What is Genscript Biotech Corporation's market cap?

Genscript Biotech Corporation's market capitalization is EUR 2.88B.

What does Genscript Biotech Corporation do?

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through Life Science Services and Products;